Literature DB >> 12559861

Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison.

Christos Pantelis1, Dennis Velakoulis, Patrick D McGorry, Stephen J Wood, John Suckling, Lisa J Phillips, Alison R Yung, Edward T Bullmore, Warrick Brewer, Bridget Soulsby, Patricia Desmond, Philip K McGuire.   

Abstract

BACKGROUND: Psychotic disorders, such as schizophrenia, are associated with neuroanatomical abnormalities, but whether these predate the onset of symptoms or develop progressively over the course of illness is unclear. We investigated this issue with MRI to study people with prodromal symptoms who are at ultra high-risk for the development of psychosis.
METHODS: We did two comparisons, cross-sectional and longitudinal. For the cross-sectional comparison, 75 people with prodromal signs of psychosis were scanned with MRI. After at least 12 months of follow-up, 23 (31%) had developed psychosis and 52 (69%) had not. Baseline MRI data from these two subgroups were compared. For the longitudinal comparison, 21 of the ultra high-risk individuals were scanned again with MRI after at least 12 months. Ten of these had developed psychosis and 11 had not. MRI data from baseline and follow-up were compared within each group of people.
FINDINGS: In the cross-sectional comparison, compared with people who did not develop psychosis, those who did develop the disorder had less grey matter in the right medial temporal, lateral temporal, and inferior frontal cortex, and in the cingulate cortex bilaterally. In the longitudinal comparison, when re-scanned, individuals who had developed psychosis showed a reduction in grey matter in the left parahippocampal, fusiform, orbitofrontal and cerebellar cortices, and the cingulate gyri. In those who had not become psychotic, longitudinal changes were restricted to the cerebellum.
INTERPRETATION: Some of the grey-matter abnormalities associated with psychotic disorders predate the onset of frank symptoms, whereas others appear in association with their first expression.

Entities:  

Mesh:

Year:  2003        PMID: 12559861     DOI: 10.1016/S0140-6736(03)12323-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  353 in total

1.  Semantic Processing and Thought Disorder in Childhood-Onset Schizophrenia: Insights from fMRI.

Authors:  L A Borofsky; K McNealy; P Siddarth; K N Wu; M Dapretto; R Caplan
Journal:  J Neurolinguistics       Date:  2010-05       Impact factor: 1.710

2.  Clinical and genetic high-risk paradigms: converging paths to psychosis meet in the temporal lobes.

Authors:  Maria Jalbrzikowski; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2011-05-15       Impact factor: 13.382

3.  Functional neuroimaging in mental disorders.

Authors:  Philip K McGuire; Kazunori Matsumoto
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

4.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

Review 5.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 6.  Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.

Authors:  Christin Schifani; Sina Hafizi; Tania Da Silva; Jeremy Joseph Watts; M Saad Khan; Romina Mizrahi
Journal:  Int Rev Psychiatry       Date:  2017-12-08

7.  MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms.

Authors:  Beng-Choon Ho
Journal:  Schizophr Res       Date:  2007-08-29       Impact factor: 4.939

8.  Diminished neural sensitivity to irregular facial expression in first-episode schizophrenia.

Authors:  Maya Bleich-Cohen; Rael D Strous; Raz Even; Pia Rotshtein; Galit Yovel; Iulian Iancu; Ahikam Olmer; Talma Hendler
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

9.  fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk.

Authors:  Xiaobo Li; Craig A Branch; Babak A Ardekani; Hilary Bertisch; Chindo Hicks; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2007-08-24       Impact factor: 4.939

Review 10.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.